Cargando…
Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
BACKGROUND: The SARS-CoV-2 pandemic has created an urgent and unprecedented need for rapid large-scale diagnostic testing to inform timely patient management. However, robust data are lacking on the relative performance of available rapid molecular tests across a full range of viral concentrations....
Autores principales: | Smithgall, Marie C., Scherberkova, Ioana, Whittier, Susan, Green, Daniel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217789/ https://www.ncbi.nlm.nih.gov/pubmed/32434706 http://dx.doi.org/10.1016/j.jcv.2020.104428 |
Ejemplares similares
-
Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs
por: Serei, Virian D., et al.
Publicado: (2021) -
Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges
por: Broder, Kari, et al.
Publicado: (2020) -
Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020) -
Recommendations for sample pooling on the Cepheid GeneXpert(®) system using the Cepheid Xpert(®) Xpress SARS-CoV-2 assay
por: Becker, Michael G., et al.
Publicado: (2020) -
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
por: Loeffelholz, Michael J., et al.
Publicado: (2020)